Jose Angel Bufill MD

Oncology•Mishawaka, IN

Director of the Cancer Genetics Program at Saint Joseph Regional Medical Center in Mishawaka

Join to View Full Profile

5340 Holy Cross PkwyMishawaka, IN 46545
Phone+1 574-237-1328
Fax+1 574-968-9442

Education & Training

New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Hematology and Medical Oncology, 1990 - 1991
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1986 - 1988
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1983 - 1986
Universidad de Navarra Faculty of MedicineClass of 1983

Certifications & Licensure

IN State Medical License 1993 - 2025
MI State Medical License 2011 - 2018
NY State Medical License 1990 - 1994
WI State Medical License 1985 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 1999

Clinical Trials

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
ACTIVE_NOT_RECRUITING
PHASE3
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 2
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 17
Completed
Phase 2
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
COMPLETED
PHASE2
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 2011 Jan 07
Completed
Phase 2
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2010 Sep 17
Completed
Phase 2
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
ACTIVE_NOT_RECRUITING
PHASE3
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma.
Ikemsinachi C Nzenwa, Margaret Berquist, Toby J Brenner, Aida Ansari, Hamid D Al-Fadhl
Case Reports in Critical Care. 2023-01-01
ASCO Voices 2020.
Daniel Rayson, Jose A. Bufill, Julia Close, Alice Cyusa, Kurt R. Oettel
Journal of Clinical Oncology. 2020-08-09
29 citations
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy
Gerald Li, Dean Pavlick, Jon Chung, Todd M. Bauer, Bradford A. Tan
Journal of Gastrointestinal Oncology. 2019-10-01

Press Mentions

American Oncologist to Conduct Lecture on Lymphoma & Breast Cancer TreatmentJanuary 4th, 2019
Mini Medical School Lecture Series Starts Wednesday at IU School of MedicineMarch 9th, 2017
A Vision of HopeMarch 1st, 2024